A Randomized, Placebo-Controlled, Single Ascending Dose Study To Assess The Safety, Tolerability and Pharmacokinetics Of CS-8080 In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2017
At a glance
- Drugs CS 8080 (Primary)
- Indications Arterial occlusive disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Daiichi Sankyo Inc
- 19 Dec 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Dec 2008 New trial record.